Oral administration of recombinant Lactococcus lactis expressing bovine β-lactoglobulin partially prevents mice from sensitization

Clinical and Experimental Allergy

Volumn 35, Issue 4, 2005, Pages 539-546

  Adel Patient, Karine ^a,c   Ah Leung, S ^a   Creminon, C ^a   Nouaille, S ^b   Chatel, J M ^a   Langella, P ^b   Wal, J M ^a  

^a Bâtiment 136 CEA de Saclay   (France)

^b CEMAGREF   (France)

^c CEA SACLAY   (France)

Author keywords

Bovine lactoglobulin; Immunomodulation; Lactococcus lactis; Oral prevention

Indexed keywords

ALLERGEN; BETA LACTOGLOBULIN; FREUND ADJUVANT; GAMMA INTERFERON; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G2A; PROBIOTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIGEN SPECIFICITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; IMMUNOLOGICAL TOLERANCE; LACTOCOCCUS LACTIS; MILK ALLERGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; SENSITIZATION; TH1 CELL; TH2 CELL;

ADMINISTRATION, ORAL; ALLERGENS; ANIMALS; ANTIBODY SPECIFICITY; CATTLE; CYTOKINES; FECES; FEMALE; FOOD HYPERSENSITIVITY; IMMUNE TOLERANCE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERFERON TYPE II; LACTOCOCCUS LACTIS; LACTOGLOBULINS; MICE; MICE, INBRED BALB C; RECOMBINATION, GENETIC; TH1 CELLS;

EID: 17744387781     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2005.02225.x     Document Type: Article

References (41)

1. European Commission Report T72. Scientific co-operation on questions relating to food: consideration of the epidemiological basis for appropriate measures for the protection of public health in respect to food allergy. European Commission Report, Task 7.2. 1998.
2. Wal J-M, Bernard H, Clement G, Chatel JM, Adel-Patient K. Characterization of allergens in milk. Curr Allergy Clin Immunol 2001; 14:4-10.
3. Ford RP, Hill DJ, Hosking CS. Cows' milk hypersensitivity: immediate and delayed onset clinical patterns. Arch Dis Child 1983; 58:856-62.
4. Hill DJ, Firer MA, Shelton MSc, Hosking MD. Manifestations of milk allergy in infancy: clinical and immunologic findings. J Pedria 1989; 109:270-9.
5. Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989; 7:145-73.
6. Fuller R. Probiotics in human medicine. Gut 1991; 32:439-42.
7. Miettinen M, Vuopio-Varkila J, Varkila K. Production of human tumor necrosis factor alpha, interleukin-6, and interleukin-10 is induced by lactic acid bacteria. Infect Immun 1996; 64:5403-5.
8. Majamaa H, Isolauri E. Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol 1997; 99:179-85.
9. Rosenfeldt V, Benfeldt E, Nielsen SD et al. Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J Allergy Clin Immunol 2003; 111:389-95.
10. Murosaki S, Yamamoto Y, Ito K et al. Heat-killed Lactobacillus plantarum L-137 suppresses naturally fed antigen-specific IgE production by stimulation of IL-12 production in mice. J Allergy Clin Immunol 1998; 102:57-64.
11. Matsuzaki T, Chin J. Modulating immune responses with probiotic bacteria. Immunol Cell Biol 2000; 78:67-73.
12. Shida K, Makino K, Morishita A et al. Lactobacillus casei inhibits antigen-induced IgE secretion through regulation of cytokine production in murine splenocyte cultures. Int Arch Allergy Immunol 1998; 115:278-87.
13. Isolauri E, Majamaa H, Arvola T, Rantala I, Virtanen E, Arvilommi H. Lactobacillus casei strain GG reverses increased intestinal permeability induced by cow milk in suckling rats. Gastroenterology 1993; 105:1643-50.
14. Repa A, Grangette C, Daniel C et al. Mucosal co-application of lactic acid bacteria and allergen induces counter-regulatory immune responses in a murine model of birch pollen allergy. Vaccine 2003; 22:87-95.
15. Pochard P, Gosset P, Grangette C et al. Lactic acid bacteria inhibit TH2 cytokine production by mononuclear cells from allergic patients. J Allergy Clin Immunol 2002; 110:617-23.
16. Steidler L, Robinson K, Chamberlain L et al. Mucosal delivery of murine interleukin-2 (IL-2) and IL-6 by recombinant strains of Lactococcus lactis coexpressing antigen and cytokine. Infect Immun 1998; 66:3183-9.
17. Robinson K, Chamberlain LM, Schofield KM, Wells JM, Le Page RW. Oral vaccination of mice against tetanus with recombinant Lactococcus lactis. Nat Biotechnol 1997; 15:653-7.
18. Chatel JM, Nouaille S, Adel-Patient K et al. Characterization of a Lactococcus lactis strain that secretes a major epitope of bovine beta-lactoglobulin and evaluation of its immunogenicity in mice. Appl Environ Microbiol 2003; 69:6620-7.
19. Chatel JM, Langella P, Adel-Patient K, Commissaire J, Wal JM, Corthier G. Induction of mucosal immune response after intranasal or oral inoculation of mice with Lactococcus lactis producing bovine beta-lactoglobulin. Clin Diag Lab Immunol 2001; 8:545-51.
20. Adel-Patient K, Nahori MA, Proust B et al. Elicitation of the allergic reaction in beta-lactoglobulin-sensitized Balb/c mice: biochemical and clinical manifestations differ according to the structure of the allergen used for challenge. Clin Exp Allergy 2003; 33:376-85.
21. Nouaille S, Bermudez-Humaran LG, Adel-Patient K et al. Improvement of bovine β-lactoglobulin production and secretion in Lactococcus lactis. Braz J Biol Med Res 2005; 38:353-9.
22. Adel-Patient K, Creminon C, Bernard H et al. Evaluation of a high IgE-responder mouse model of allergy to bovine beta-lactoglobulin (BLG): development of sandwich immunoassays for total and allergen-specific IgE, IgG1 and IgG2a in BLG-sensitized mice. J Immunol Methods 2000; 235:21-32.
23. Adel-Patient K, Creminon C, Boquet D, Wal JM, Chatel JM. Genetic Immunisation with Bovine beta-Lactoglobulin cDNA Induces a Preventive and Persistent Inhibition of Specific Anti-BLG IgE Response in Mice. Int Arch Allergy Immunol 2001; 126:59-67.
24. Eum SY, Haile S, Lefort J, Huerre M, Vargaftig BB. Eosinophil recruitment into the respiratory epithelium following antigenic challenge in hyper-IgE mice is accompanied by interleukin 5-dependent bronchial hyperresponsiveness. Proc Natl Acad Sci USA 1995; 92:12290-4.
25. Le Loir Y, Gruss A, Ehrlich SD, Langella P. A nine-residue synthetic propeptide enhances secretion efficiency of heterologous proteins in Lactococcus lactis. J Bacteriol 1998; 180:1895-903.
26. Prioult G, Fliss I, Pecquet S. Effect of probiotic bacteria on induction and maintenance of oral tolerance to beta-lactoglobulin in gnotobiotic mice. Clin Diagn Lab Immunol 2003; 10:787-92.
27. Fang H, Elina T, Heikki A, Seppo S. Modulation of humoral immune response through probiotic intake. FEMS Immunol Med Microbiol 2000; 29:47-52.
28. Drouault S, Corthier G, Ehrlich SD, Renault P. Survival, physiology, and lysis of Lactococcus lactis in the digestive tract. Appl Environ Microbiol 1999; 65:4881-6.
29. Steidler L, Hans W, Schotte L et al. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 2000; 289:1352-5.
30. Bermudez-Humaran LG, Langella P, Commissaire J et al. Controlled intra- or extracellular production of staphylococcal nuclease and ovine omega interferon in Lactococcus lactis. FEMS Microbiol Lett 2003; 224:307-13.
31. Weiner HL. The mucosal milieu creates tolerogenic dendritic cells and T(R)1 and T(H)3 regulatory cells. Nat Immunol 2001; 2:671-2.
32. Hofstra CL, Van Ark I, Hofman G, Nijkamp FP, Jardieu PM, Van Oosterhout AJ. Differential effects of endogenous and exogenous interferon-gamma on immunoglobulin E, cellular infiltration, and airway responsiveness in a murine model of allergic asthma. Am J Respir Cell Mol Biol 1998; 19:826-35.
33. Sur S, Wild JS, Choudhury BK, Sur N, Alam R, Klinman DM. Long term prevention of allergic lung inflammation in a mouse model of asthma by CpG oligodeoxynucleotides. J Immunol 1999; 162:6284-93.
34. Suto A, Nakajima H, Hirose K et al. Interleukin 21 prevents antigen-induced IgE production by inhibiting germ line C(epsilon) transcription of IL-4-stimulated B cells. Blood 2002; 100:4565-73.
35. Yoshida K, Matsuoka M, Usuda S, Mori A, Ishizaka K, Sakano H. Immunoglobulin switch circular DNA in the mouse infected with Nipposirongylus brasiliensis: evidence for successive class switching from mu to epsilon via gamma 1. Proc Natl Acad Sci USA 1990; 87:7829-33.
36. Grangette C, Muller-Alouf H, Goudercourt D, Geoffroy MC, Turneer M, Mercenier A. Mucosal immune responses and protection against tetanus toxin after intranasal immunization with recombinant Lactobacillus plantarum. Infect Immunol 2001; 69:1547-53.
37. Chatel JM, Bernard H, Clement G et al. Expression, purification and immunochemical characterization of recombinant bovine beta-lactoglobulin, a major cow milk allergen. Mol Immunol 1996; 33:1113-8.
38. Dahlman A, Ahlstedt S, Hanson LA, Telemo E, Wold AE, Dahlgren UI. Induction of IgE antibodies and T-cell reactivity to ovalbumin in rats colonized with Escherichia coli genetically manipulated to produce ovalbumin. Immunology 1992; 76: 225-8.
39. Li XM, Srivastava K, Huleatt JW, Bottomly K, Burks AW, Sampson HA. Engineered recombinant peanut protein and heat-killed Listeria monocytogenes coadministration protects against peanut-induced anaphylaxis in a murine model. J Immunol 2003; 170:3289-95.
40. Bermudez-Humaran LG, Langella P, Cortes-Perez NG et al. Intranasal immunization with recombinant Lactococcus lactis secreting murine interleukin-12 enhances antigen-specific Th1 cytokine production. Infect Immunol 2003; 71:1887-96.
41. van Asseldonk M, Rutten G, Oteman M, Siezen RJ, de Vos WM, Simons G. Cloning of usp45, a gene encoding a secreted protein from Lactococcus lactis subsp lactis MG1363. Gene 1990; 95: 155-60.